Similarly, interventions that help activate this PPARGC1A have been demonstrated to elicit enhanced cognitive performance and lower neurodegeneration in AD models, thus lending further credence to the role of this pathway as a therapeutic target in AD (46). The gene discussed is PPARGC1A; the disease is Alzheimer disease.